BioFocus - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: May 15, 2015
Pages: 38
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B6D38220F2DEN
Leaflet:

Download PDF Leaflet

BioFocus - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

BioFocus is a drug discovery company. The company delivers pre-clinical drug candidates in all therapeutic areas with capabilities in neurodegenerative diseases, inflammatory diseases and rare and neglected diseases. Its drug discovery services include integrated drug discovery, target discovery, assay development and screening, medicinal chemistry, structural biology, fragment-based drug discovery, ADME, in silico drug discovery, and compound libraries. BioFocus delivers clinical candidates in the therapeutic areas of neurodegenerative diseases, inflammatory diseases, and rare and neglected diseases. The company has research centers in the UK and the Netherlands, and business development offices in Hong Kong, Japan and the US. It operates as a subsidiary of Galapagos NV. BioFocus is headquartered in Essex, the UK.

BioFocus - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
BioFocus, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
BioFocus, Medical Devices Deals, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare, Deal Details
Partnerships
BioFocus Enters Into Drug Discovery Agreement With Boehringer Ingelheim
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson's Disease
BioFocus Enters Into Agreement With ChanTest
Ono Pharma Enters Into Discovery Agreement With BioFocus For CNS Drugs
Activiomics Enters Into Drug Discovery Agreement With BioFocus
Ono Pharma Enters Into Drug Discovery Agreement With BioFocus
Almirall Enters Into Integrated Drug Discovery Collaboration With BioFocus
BioFocus Enters Into Co-Marketing Agreement With InterMed Discovery
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson's Disease
BioFocus Extends Its Collaboration With Usher III Initiative
BioFocus Enters Into Co-Development Agreement With Astellas Pharma
BioFocus Enters Into An Agreement With Almac Group
Ono Pharma Enters Into Co-Development Agreement With BioFocus
BioFocus Extends Co-Development Agreement With Amgen
BioFocus Enters Into Drug Discovery Collaboration With Usher III Initiative
BioFocus Enters Into Co-Marketing Agreement With DiscoveRx
BioFocus Expands Collaboration With Schering-Plough
Oncodesign Enters Into Collaboration With BioFocus DPI
BioFocus Enters Into Co-Development Agreement With Medicines for Malaria Venture
BioFocus Extends Research Agreement With Eli Lilly
Licensing Agreements
ReNeuron Enters Into Licensing Agreement With BioFocus DPI
Acquisition
Charles River Labs Completes Acquisition Of BioFocus And Argenta Discovery From Galapagos For US$179 Million
BioFocus - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES
BioFocus, Pharmaceuticals & Healthcare, Key Facts
BioFocus, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
BioFocus, Deals By Therapy Area, 2009 to YTD 2015
BioFocus, Medical Devices Deals, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
BioFocus Enters Into Drug Discovery Agreement With Boehringer Ingelheim
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson's Disease
BioFocus Enters Into Agreement With ChanTest
Ono Pharma Enters Into Discovery Agreement With BioFocus For CNS Drugs
Activiomics Enters Into Drug Discovery Agreement With BioFocus
Ono Pharma Enters Into Drug Discovery Agreement With BioFocus
Almirall Enters Into Integrated Drug Discovery Collaboration With BioFocus
BioFocus Enters Into Co-Marketing Agreement With InterMed Discovery
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson's Disease
BioFocus Extends Its Collaboration With Usher III Initiative
BioFocus Enters Into Co-Development Agreement With Astellas Pharma
BioFocus Enters Into An Agreement With Almac Group
Ono Pharma Enters Into Co-Development Agreement With BioFocus
BioFocus Extends Co-Development Agreement With Amgen
BioFocus Enters Into Drug Discovery Collaboration With Usher III Initiative
BioFocus Enters Into Co-Marketing Agreement With DiscoveRx
BioFocus Expands Collaboration With Schering-Plough
Oncodesign Enters Into Collaboration With BioFocus DPI
BioFocus Enters Into Co-Development Agreement With Medicines for Malaria Venture
BioFocus Extends Research Agreement With Eli Lilly
ReNeuron Enters Into Licensing Agreement With BioFocus DPI
Charles River Labs Completes Acquisition Of BioFocus And Argenta Discovery From Galapagos For US$179 Million
BioFocus, Key Competitors
BioFocus, Key Employees
BioFocus, Other Locations

LIST OF FIGURES
BioFocus, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
BioFocus, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
BioFocus, Medical Devices Deals, 2009 to YTD 2015
Skip to top


Ask Your Question

BioFocus - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: